2018-2023 Global Pandemic Influenza Vaccine Consumption Market Report
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Pandemic Influenza Vaccine market for 2018-2023.
Influenza vaccines treat influenza by developing antibodies in the body within two weeks after vaccination. These antibodies protect against infections with the help of the attenuated viruses in the vaccine. These vaccines contain killed or inactivated strains of the influenza virus.
Over the next five years, LPI(LP Information) projects that Pandemic Influenza Vaccine will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Pandemic Influenza Vaccine market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Influenza A (H1N1) Vaccines
Other
Segmentation by application:
Adult
Paediatric
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
AstraZeneca
GlaxoSmithKline
Novartis
Sanofi
Valneva
Lupin
Chiron Panacea
Solvay and Serum Institute of India Pvt. Ltd.
Sementis
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Pandemic Influenza Vaccine consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Pandemic Influenza Vaccine market by identifying its various subsegments.
Focuses on the key global Pandemic Influenza Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pandemic Influenza Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pandemic Influenza Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2018-2023 Global Pandemic Influenza Vaccine Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pandemic Influenza Vaccine Consumption 2013-2023
2.1.2 Pandemic Influenza Vaccine Consumption CAGR by Region
2.2 Pandemic Influenza Vaccine Segment by Type
2.2.1 Influenza A (H1N1) Vaccines
2.2.2 Other
2.3 Pandemic Influenza Vaccine Consumption by Type
2.3.1 Global Pandemic Influenza Vaccine Consumption Market Share by Type (2013-2018)
2.3.2 Global Pandemic Influenza Vaccine Revenue and Market Share by Type (2013-2018)
2.3.3 Global Pandemic Influenza Vaccine Sale Price by Type (2013-2018)
2.4 Pandemic Influenza Vaccine Segment by Application
2.4.1 Adult
2.4.2 Paediatric
2.5 Pandemic Influenza Vaccine Consumption by Application
2.5.1 Global Pandemic Influenza Vaccine Consumption Market Share by Application (2013-2018)
2.5.2 Global Pandemic Influenza Vaccine Value and Market Share by Application (2013-2018)
2.5.3 Global Pandemic Influenza Vaccine Sale Price by Application (2013-2018)
3 Global Pandemic Influenza Vaccine by Players
3.1 Global Pandemic Influenza Vaccine Sales Market Share by Players
3.1.1 Global Pandemic Influenza Vaccine Sales by Players (2016-2018)
3.1.2 Global Pandemic Influenza Vaccine Sales Market Share by Players (2016-2018)
3.2 Global Pandemic Influenza Vaccine Revenue Market Share by Players
3.2.1 Global Pandemic Influenza Vaccine Revenue by Players (2016-2018)
3.2.2 Global Pandemic Influenza Vaccine Revenue Market Share by Players (2016-2018)
3.3 Global Pandemic Influenza Vaccine Sale Price by Players
3.4 Global Pandemic Influenza Vaccine Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Pandemic Influenza Vaccine Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Pandemic Influenza Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Pandemic Influenza Vaccine by Regions
4.1 Pandemic Influenza Vaccine by Regions
4.1.1 Global Pandemic Influenza Vaccine Consumption by Regions
4.1.2 Global Pandemic Influenza Vaccine Value by Regions
4.2 Americas Pandemic Influenza Vaccine Consumption Growth
4.3 APAC Pandemic Influenza Vaccine Consumption Growth
4.4 Europe Pandemic Influenza Vaccine Consumption Growth
4.5 Middle East & Africa Pandemic Influenza Vaccine Consumption Growth
5 Americas
5.1 Americas Pandemic Influenza Vaccine Consumption by Countries
5.1.1 Americas Pandemic Influenza Vaccine Consumption by Countries (2013-2018)
5.1.2 Americas Pandemic Influenza Vaccine Value by Countries (2013-2018)
5.2 Americas Pandemic Influenza Vaccine Consumption by Type
5.3 Americas Pandemic Influenza Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Pandemic Influenza Vaccine Consumption by Countries
6.1.1 APAC Pandemic Influenza Vaccine Consumption by Countries (2013-2018)
6.1.2 APAC Pandemic Influenza Vaccine Value by Countries (2013-2018)
6.2 APAC Pandemic Influenza Vaccine Consumption by Type
6.3 APAC Pandemic Influenza Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Pandemic Influenza Vaccine by Countries
7.1.1 Europe Pandemic Influenza Vaccine Consumption by Countries (2013-2018)
7.1.2 Europe Pandemic Influenza Vaccine Value by Countries (2013-2018)
7.2 Europe Pandemic Influenza Vaccine Consumption by Type
7.3 Europe Pandemic Influenza Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Pandemic Influenza Vaccine by Countries
8.1.1 Middle East & Africa Pandemic Influenza Vaccine Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Pandemic Influenza Vaccine Value by Countries (2013-2018)
8.2 Middle East & Africa Pandemic Influenza Vaccine Consumption by Type
8.3 Middle East & Africa Pandemic Influenza Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Pandemic Influenza Vaccine Distributors
10.3 Pandemic Influenza Vaccine Customer
11 Global Pandemic Influenza Vaccine Market Forecast
11.1 Global Pandemic Influenza Vaccine Consumption Forecast (2018-2023)
11.2 Global Pandemic Influenza Vaccine Forecast by Regions
11.2.1 Global Pandemic Influenza Vaccine Forecast by Regions (2018-2023)
11.2.2 Global Pandemic Influenza Vaccine Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Pandemic Influenza Vaccine Forecast by Type
11.8 Global Pandemic Influenza Vaccine Forecast by Application
12 Key Players Analysis
12.1 AstraZeneca
12.1.1 Company Details
12.1.2 Pandemic Influenza Vaccine Product Offered
12.1.3 AstraZeneca Pandemic Influenza Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 AstraZeneca News
12.2 GlaxoSmithKline
12.2.1 Company Details
12.2.2 Pandemic Influenza Vaccine Product Offered
12.2.3 GlaxoSmithKline Pandemic Influenza Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 GlaxoSmithKline News
12.3 Novartis
12.3.1 Company Details
12.3.2 Pandemic Influenza Vaccine Product Offered
12.3.3 Novartis Pandemic Influenza Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Novartis News
12.4 Sanofi
12.4.1 Company Details
12.4.2 Pandemic Influenza Vaccine Product Offered
12.4.3 Sanofi Pandemic Influenza Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Sanofi News
12.5 Valneva
12.5.1 Company Details
12.5.2 Pandemic Influenza Vaccine Product Offered
12.5.3 Valneva Pandemic Influenza Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Valneva News
12.6 Lupin
12.6.1 Company Details
12.6.2 Pandemic Influenza Vaccine Product Offered
12.6.3 Lupin Pandemic Influenza Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Lupin News
12.7 Chiron Panacea
12.7.1 Company Details
12.7.2 Pandemic Influenza Vaccine Product Offered
12.7.3 Chiron Panacea Pandemic Influenza Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Chiron Panacea News
12.8 Solvay and Serum Institute of India Pvt. Ltd.
12.8.1 Company Details
12.8.2 Pandemic Influenza Vaccine Product Offered
12.8.3 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Solvay and Serum Institute of India Pvt. Ltd. News
12.9 Sementis
12.9.1 Company Details
12.9.2 Pandemic Influenza Vaccine Product Offered
12.9.3 Sementis Pandemic Influenza Vaccine Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Sementis News
13 Research Findings and Conclusion
